Lipoprotein(a).
作者信息
Scott J
出版信息
BMJ. 1991 Sep 21;303(6804):663-4. doi: 10.1136/bmj.303.6804.663.
Abstract
摘要
相似文献
1
Lipoprotein(a).脂蛋白(a)
BMJ. 1991 Sep 21;303(6804):663-4. doi: 10.1136/bmj.303.6804.663.
2
Lp(a) as a marker for coronary heart disease risk.
Clin Cardiol. 1991 Feb;14(2 Suppl 1):I35-9. doi: 10.1002/clc.4960141306.
3
[Lipoprotein (a); a new 'independent' risk factor for atherosclerosis].[脂蛋白(a)：动脉粥样硬化的一种新的“独立”危险因素]
Ned Tijdschr Geneeskd. 1992 Apr 11;136(15):730-4.
4
Lipoprotein(a), atherosclerosis and thrombosis.
Prog Lipid Res. 1991;30(2-3):189-94. doi: 10.1016/0163-7827(91)90015-w.
5
[Lp(a): a little known, independent atherogenic risk factor].[脂蛋白(a)：一个鲜为人知的独立致动脉粥样硬化危险因素]
Med Welt. 1984 Jan 20;35(3):92-5.
6
[Lipoprotein (a)].[脂蛋白(a)]
Med Clin (Barc). 1991 Oct 12;97(12):453-5.
7
[Metabolism and clinical significance of lipoprotein Lp(a) (author's transl)].脂蛋白Lp(a)的代谢及其临床意义（作者译）
Acta Med Austriaca. 1980;7(4-5):101-3.
8
[Lipoprotein (a)--a further risk factor in arteriosclerosis?].[脂蛋白(a)——动脉硬化的另一个危险因素？]
Fortschr Med. 1990 Oct 10;108(29):547-9, 554.
9
Studies of platelet adhesiveness, glucose tolerance and serum liporotein patterns in patients with coronary artery disease.冠状动脉疾病患者的血小板黏附性、葡萄糖耐量和血清脂蛋白模式研究。
Am J Med Sci. 1972 Dec;264(6):475-83. doi: 10.1097/00000441-197212000-00006.
10
[Lipoprotein(a) as a risk factor for arteriosclerosis].[脂蛋白(a)作为动脉硬化的一个风险因素]
Internist (Berl). 1992 Jan;33(1):24-31.
引用本文的文献
1
Lipoprotein (a) as an independent risk factor for myocardial infarction in patients with common hypercholesterolaemia.脂蛋白(a)作为普通高胆固醇血症患者心肌梗死的独立危险因素。
J Clin Pathol. 1993 Mar;46(3):267-70. doi: 10.1136/jcp.46.3.267.
2
Increased incidence of coronary disease in people with impaired glucose tolerance: link with increased lipoprotein(a) concentrations?糖耐量受损人群冠心病发病率增加：与脂蛋白(a)浓度升高有关？
BMJ. 1992 Jun 20;304(6842):1610-1. doi: 10.1136/bmj.304.6842.1610.
本文引用的文献
1
Influence of nicotinic acid on metabolism of cholesterol and triglycerides in man.烟酸对人体胆固醇及甘油三酯代谢的影响。
J Lipid Res. 1981 Jan;22(1):24-36.
2
Reduction of lecithin-cholesterol acyltransferase, apolipoprotein D and the Lp(a) lipoprotein with the anabolic steroid stanozolol.
Biochim Biophys Acta. 1984 Sep 12;795(2):293-6. doi: 10.1016/0005-2760(84)90078-x.
3
Complete protein sequence and identification of structural domains of human apolipoprotein B.人类载脂蛋白B的完整蛋白质序列及结构域鉴定
Nature. 1986;323(6090):734-8. doi: 10.1038/323734a0.
4
Lp(a) lipoprotein in patients with chronic renal failure treated by hemodialysis.血液透析治疗的慢性肾衰竭患者中的脂蛋白(a)
Clin Chem. 1987 May;33(5):721.
5
Fat feeding in humans induces lipoproteins of density less than 1.006 that are enriched in apolipoprotein [a] and that cause lipid accumulation in macrophages.在人体中，摄入脂肪会诱导产生密度小于1.006的脂蛋白，这些脂蛋白富含载脂蛋白[a]，并会导致巨噬细胞脂质蓄积。
J Clin Invest. 1986 Feb;77(2):622-30. doi: 10.1172/JCI112345.
6
Lack of effect of probucol on serum lipoprotein(a) levels.普罗布考对血清脂蛋白(a)水平无影响。
Atherosclerosis. 1989 Oct;79(2-3):267-9. doi: 10.1016/0021-9150(89)90134-2.
7
A potential basis for the thrombotic risks associated with lipoprotein(a).与脂蛋白(a)相关的血栓形成风险的潜在基础。
Nature. 1989 May 25;339(6222):301-3. doi: 10.1038/339301a0.
8
Interrelationships between plasma levels of plasminogen activator inhibitor, tissue plasminogen activator, lipoprotein (a), and established cardiovascular risk factors in a north Swedish population.瑞典北部人群中纤溶酶原激活物抑制剂、组织纤溶酶原激活物、脂蛋白(a)的血浆水平与既定心血管危险因素之间的相互关系。
Atherosclerosis. 1989 Nov;80(1):9-16. doi: 10.1016/0021-9150(89)90062-2.
9
Lp(a) lipoprotein concentration in serum of patients with heavy proteinuria of different origin.不同病因的重度蛋白尿患者血清中的脂蛋白（a）浓度
Clin Chem. 1989 Oct;35(10):2121-3.
10
Detection and quantification of lipoprotein(a) in the arterial wall of 107 coronary bypass patients.107例冠状动脉搭桥患者动脉壁中脂蛋白(a)的检测与定量分析。
Arteriosclerosis. 1989 Sep-Oct;9(5):579-92. doi: 10.1161/01.atv.9.5.579.
Zotero 插件